Targeting cancer gene dependencies with anthrax-mediated delivery of peptide nucleic acids
Copyright © 2020 American Chemical Society. Antisense oligonucleotide therapies are important cancer treatments, which can suppress genes in cancer cells that are critical for cell survival. SF3B1 has recently emerged as a promising gene target that encodes a key splicing factor in the SF3B protein...
Main Authors: | Lu, Zeyu, Paolella, Brenton R, Truex, Nicholas L, Loftis, Alexander R, Liao, Xiaoli, Rabideau, Amy E, Brown, Meredith S, Busanovich, John, Beroukhim, Rameen, Pentelute, Bradley L |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society (ACS)
2021
|
Online Access: | https://hdl.handle.net/1721.1/135910 |
Similar Items
-
Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids
by: Lu, Zeyu, et al.
Published: (2022) -
Delivery of Antibody Mimics into Mammalian Cells via Anthrax Toxin Protective Antigen
by: Liao, Xiaoli, et al.
Published: (2014) -
Delivery of biomolecules into mammalian cells using anthrax toxin
by: Rabideau, Amy Ellen
Published: (2016) -
Anthrax Protective Antigen Retargeted with Single‐Chain Variable Fragments Delivers Enzymes to Pancreatic Cancer Cells
by: Loftis, Alexander Robert, et al.
Published: (2020) -
Delivery of mirror image polypeptides into cells
by: Rabideau, Amy E., et al.
Published: (2015)